Found: 32
Select item for more details and to access through your institution.
Therapy of a clear cell adenocarcinoma of unknown primary arising in the abdominal wall after cesarean section and after hysterectomy.
- Published in:
- 2015
- By:
- Publication type:
- Report
Correlation of circular RNA abundance with proliferation - exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues.
- Published in:
- Scientific Reports, 2015, p. 8057, doi. 10.1038/srep08057
- By:
- Publication type:
- Article
Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer.
- Published in:
- Oncology Letters, 2017, v. 13, n. 6, p. 4047, doi. 10.3892/ol.2017.5969
- By:
- Publication type:
- Article
Die prognostische Bedeutung prätherapeutischer Butyrylcholinesterase-Serumspiegel in Zervixkarzinompatientinnen unter primärer (Chemo‑)Radiotherapie.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. e1060, doi. 10.1634/theoncologist.2019-0904
- By:
- Publication type:
- Article
EV-Associated MMP9 in High-Grade Serous Ovarian Cancer Is Preferentially Localized to Annexin V-Binding EVs.
- Published in:
- Disease Markers, 2017, p. 1, doi. 10.1155/2017/9653194
- By:
- Publication type:
- Article
PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85966-0
- By:
- Publication type:
- Article
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer.
- Published in:
- Journal of Gynecologic Oncology, 2021, v. 32, n. 1, p. 1, doi. 10.3802/jgo.2021.32.e1
- By:
- Publication type:
- Article
Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182383
- By:
- Publication type:
- Article
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-178
- By:
- Publication type:
- Article
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-115
- By:
- Publication type:
- Article
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133210
- By:
- Publication type:
- Article
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1780, doi. 10.3390/cancers14071780
- By:
- Publication type:
- Article
Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5865, doi. 10.3390/cancers13235865
- By:
- Publication type:
- Article
Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2519, doi. 10.3390/cancers12092519
- By:
- Publication type:
- Article
A Global Gene Body Methylation Measure Correlates Independently with Overall Survival in Solid Cancer Types.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2257, doi. 10.3390/cancers12082257
- By:
- Publication type:
- Article
Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 548, doi. 10.3390/cancers12030548
- By:
- Publication type:
- Article
Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 505, doi. 10.3390/cancers12020505
- By:
- Publication type:
- Article
NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 698, doi. 10.3390/cancers11050698
- By:
- Publication type:
- Article
A modified technique of laparoscopic ovarian drilling for polycystic ovary syndrome using the monopolar hook electrode.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2011, v. 90, n. 5, p. 547, doi. 10.1111/j.1600-0412.2011.01103.x
- By:
- Publication type:
- Article
Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 9, p. N.PAG, doi. 10.3390/jpm12091467
- By:
- Publication type:
- Article
Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 4, p. 551, doi. 10.3390/jpm12040551
- By:
- Publication type:
- Article
Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 1, p. 48, doi. 10.3390/jpm11010048
- By:
- Publication type:
- Article
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 188, doi. 10.3390/jpm10040188
- By:
- Publication type:
- Article
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140403
- By:
- Publication type:
- Article
Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-67
- By:
- Publication type:
- Article
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium.
- Published in:
- Molecular Cancer, 2012, v. 11, n. 1, p. 69, doi. 10.1186/1476-4598-11-69
- By:
- Publication type:
- Article
Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium.
- Published in:
- Cancer Science, 2012, v. 103, n. 7, p. 1334, doi. 10.1111/j.1349-7006.2012.02306.x
- By:
- Publication type:
- Article